article thumbnail

Sorry, the Inflation Bill won’t lower healthcare costs

World of DTC Marketing

The Inflation Reduction Act’s health insurance subsidies and drug pricing reforms will improve health care affordability for Americans but won’t do a damn thing for our overall healthcare costs, which will keep rising. A staggering 85% of healthcare costs in the U.S. Finally, there are healthcare administrative costs.

article thumbnail

New FDA head needs to examine the accelerated approval program

World of DTC Marketing

Between 2011 and 2018, cumulative spending on 44 FDA-approved oral targeted therapy drugs was $3.5 This is another example of just how screwed up our healthcare system really is. billion, with more than half of that devoted to products that did not provide a “documented overall survival benefit” in clinical trials.

FDA 234
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 12 Healthcare Technology Start-ups To Know

Medico Reach

The healthcare sector has seen a few developments over the years. Tempus began with the goal of incorporating artificial intelligence and data science into the healthcare industry. Collective Healthcare develops intelligent solutions to help US organizations provide better employee healthcare coverage. billion in 2022.

article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

To achieve this objective, the regulation amends Directive 2011/24/EU on the application of patients’ rights in cross?border border healthcare, specifically by repealing Article 15, which originally laid down the modalities and principles for co-operation between Member States in assessing new health technologies. About the authors.

article thumbnail

New antibody drug formulation wins novel MHRA approval

European Pharmaceutical Review

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the first product via its new International Recognition Procedure (IRP). Launched in January 2024, the IRP enables the MHRA to accelerate the assessment of new medicines and thus allow patients in the UK to access treatments earlier.

article thumbnail

Innovating allergy drug delivery with a needle-free alternative

European Pharmaceutical Review

In the UK, ARS Pharmaceuticals anticipates filing for approval from the Medicines and Healthcare products Regulatory Agency (MHRA) by Q4 2024, under their Mutual Recognition Process A, where MHRA will review and approve EURneffy based on the EMA approval within 60 days of filing. Hand (N Y). 2007; 2(1):5-11.

article thumbnail

Five Years of Forbes | Legacy MEDSearch Ranks on the Forbes Best Executive Recruitment Firms for a Fifth Consecutive Year

Legacy MEDSearch

Leadership includes Joy Celebre (recruiting since 1996, joined in 2008), Carolyn Jones (recruiting since 1995, joined in 2011), Arshad Alam (recruiting since 1995, joined 2017), John White (Talent Sourcing Manager, joined 2012), and Partner Chris Miclot, (joined 2012). “In